COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
Moderna receives FDA approval to expand indication of mRESVIA vaccine for adults aged 18-59 at increased risk of RSV, based on Phase 3 study results showing safety and efficacy -
-
-
COMMUNIQUÉ DE PRESSE
Grande Portage Closes Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Grande Portage closes non-brokered private placement of 22,500,000 Units at $0.20 per Unit for gross proceeds of $4,500,000. Offering under National Instrument 45-106, aims for exploration and development of New Amalga Gold project -
-
COMMUNIQUÉ DE PRESSE
Slam Raises $350,000 in Flow-Through Private Placement, Resignation of a Director and Appointment of a New Director and Appointment of Vice President
SLAM Exploration Ltd. closes non-brokered flow-through private placement, issues 10M FT Units at $0.035 for $350K. Board changes and insider participation announced -
-
-
